NCT01781234View on ClinicalTrials.gov

Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Tobacco Abstinence Syndrome
Interventions
DRUG

Intranasal Insulin

DRUG

Placebo

Trial Locations (1)

87131

UNM College of Pharmacy, Albuquerque

All Listed Sponsors
lead

Ajna Hamidovic

OTHER

NCT01781234 - Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome | Biotech Hunter | Biotech Hunter